Drugs / PDC31
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01250587 | Nov 2010 → Jun 2012 | primary dysmenorrhea | PDC Biotech GmbH | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PDC31 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01250587 ↗ |
| Route | Intravenous | “intravenous administration (infusion)” NCT01250587 ↗ |